Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rugang Zhang

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Molecular and Cellular Biology|November 15, 2006
HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cellsRugang Zhang, Song-tao Liu, Wei Chen, et al.
Molecular & Cellular Proteomics : MCP|September 23, 2016
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional LevelAaron R Goldman, Benjamin G Bitler, Zachary Schug, et al.
Molecular Cancer Research : MCR|June 15, 2016
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for MelanomaNail Fatkhutdinov, Katrin Sproesser, Clemens Krepler, et al.
The Journal of Biological Chemistry|November 3, 2009
Identification of a functional network of human epigenetic silencing factorsAndrey Poleshko, Margret B Einarson, Natalia Shalginskikh, et al.
Journal of Virology|December 21, 2007
Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral responseAndrey Poleshko, Ivan Palagin, Rugang Zhang, et al.
Cancer Research|December 21, 2019
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian CancerTimothy Nacarelli, Takeshi Fukumoto, Joseph A Zundell, et al.
Nature Cell Biology|April 2, 2021
m<sup>6</sup>A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotypePingyu Liu, Fuming Li, Jianhuang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i>-Mutant Ovarian Cancer ModelsHyoung Kim, Erin George, Ryan Ragland, et al.
Frontiers in Public Health|January 23, 2025
Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021Quanwei He, Xiujuan Chang, Ran Xu, et al.
Medicine|November 26, 2019
Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradientYiming Zhao, Liangliang Guo, Qiyang Huang, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Molecular and Cellular Biology|November 15, 2006
HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cellsRugang Zhang, Song-tao Liu, Wei Chen, et al.
Molecular & Cellular Proteomics : MCP|September 23, 2016
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional LevelAaron R Goldman, Benjamin G Bitler, Zachary Schug, et al.
Molecular Cancer Research : MCR|June 15, 2016
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for MelanomaNail Fatkhutdinov, Katrin Sproesser, Clemens Krepler, et al.
The Journal of Biological Chemistry|November 3, 2009
Identification of a functional network of human epigenetic silencing factorsAndrey Poleshko, Margret B Einarson, Natalia Shalginskikh, et al.
Journal of Virology|December 21, 2007
Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral responseAndrey Poleshko, Ivan Palagin, Rugang Zhang, et al.
Cancer Research|December 21, 2019
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian CancerTimothy Nacarelli, Takeshi Fukumoto, Joseph A Zundell, et al.
Nature Cell Biology|April 2, 2021
m<sup>6</sup>A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotypePingyu Liu, Fuming Li, Jianhuang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i>-Mutant Ovarian Cancer ModelsHyoung Kim, Erin George, Ryan Ragland, et al.
Frontiers in Public Health|January 23, 2025
Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021Quanwei He, Xiujuan Chang, Ran Xu, et al.
Medicine|November 26, 2019
Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradientYiming Zhao, Liangliang Guo, Qiyang Huang, et al.
Pageof 15